Premature rupture of the membranes: An evidence-based approach to clinical care

American Journal of Perinatology

Volumn 18, Issue 7, 2001, Pages 397-413

  Naylor, C S ^a   Gregory, K ^a   Hobel, C ^a  

^a NONE   (United States)

Author keywords

Clinical management; Premature rupture of membranes; PROM

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; UTERUS SPASMOLYTIC AGENT;

ADULT; ANAMNESIS; ARTICLE; BACTERIUM CULTURE; CHORIOAMNIONITIS; DELIVERY; DRUG INDICATION; EVIDENCE BASED MEDICINE; FEMALE; FETUS; FETUS LUNG MATURITY; FETUS MONITORING; GESTATIONAL AGE; HUMAN; NEWBORN; NEWBORN DISEASE; NEWBORN INFECTION; NEWBORN SEPSIS; PERINATAL CARE; PERINATOLOGY; PRACTICE GUIDELINE; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PUERPERAL DISORDER; RISK FACTOR; TREATMENT INDICATION; UTERINE CERVIX CYTOLOGY;

ADRENAL CORTEX HORMONES; AMBULATORY CARE; ANTIBIOTIC PROPHYLAXIS; BIOLOGICAL MARKERS; CERCLAGE, CERVICAL; CHORIOAMNIONITIS; DELIVERY, OBSTETRIC; EVIDENCE-BASED MEDICINE; FEMALE; FETAL DISTRESS; FETAL MEMBRANES, PREMATURE RUPTURE; FETAL MONITORING; FETAL ORGAN MATURITY; GESTATIONAL AGE; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; LABOR ONSET; LUNG; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TOCOLYSIS;

EID: 0035210144     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-18699     Document Type: Article

References (133)

1. Management of premature rupture of membranes and unfavorable cervix in term pregnancy
2. Causes of perinatal mortality in the U.S. Collaborative perinatal project
3. Management of preterm premature rupture of membranes: Lack of a national consensus
4. Amniotic fluid arborization: Effect of blood, meconium, and pH alterations
5. A technique for the detection of rupture of the membranes: A review and preliminary report
6. Risks for premature rupture of amniotic membranes
7. Cervical dilation: Accuracy of visual and digital examinations
8. Is there a need for digital examination in patients with spontaneous rupture of membranes?
9. Prolongation of the latent period in patients with premature rupture of the membranes by avoiding digital vaginal examination
10. Management of premature rupture of membranes: The risk of vaginal examination to the infant
11. The impact of digital cervical examination on expectantly managed preterm rupture of membranes
12. Effects of digital vabinal examinations on latency period in preterm premature rupture of membranes
13. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery
14. The preterm prediction study: Prediction of preterm premature rupture of membranes through clinical findings and ancillary testing
15. Prospective randomized study of corticosteroids in the management of premature rupture of the membranes and the premature gestation
16. Preterm delivery from 34 to 37 weeks of gestation: Is respiratory distress syndrome a problem?
17. Infection and labor VII: Microbial invasion of the amniotic cavity in spontaneous rupture of membranes at term
18. Biparietal diameter in premature rupture of membranes: Errors in estimating gestation age
19. Premature spontaneous rupture of the membranes
20. Fetal hazards after rupture of the membranes: A report from the collaborative project
21. Premature rupture of the membranes and prolonged latency
22. Induction of labor compared with expectant management for prelabor rupture of the membranes at term
23. Prostaglandin E2 for induction of labor in patients with premature rupture of membranes at term
24. A comparison of intrapartum versus immediate postpartum treatment of intraamniotic infection
25. Intrapartum treatment of acute chorioamnionitis: Impact on neonatal sepsis
26. A randomized trial of intrapartum versus immediate postpartum treatment of women with intra-amniotic infection
27. Induction versus expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: A randomized trial
28. Fetal heart rate patterns and fetal distress in patients with preterm premature rupture of membranes
29. Premature rupture of the membranes before 28 weeks: Conservative management
30. Nonstress testing with acoustic stimulation and amniotic fluid volume assessment: 5973 tests without unexpected fetal death
31. Predicting fetal health with the biophysical profile
32. The fetal biophysical profile in patients with premature rupture of the membranes: An early prediction of fetal infection
33. Premature rupture of the membranes: The enigma of the obstetrician
34. Intensive antenatal testing for women with preterm premature rupture of the membranes
35. The use of the nonstress test in patients with premature rupture of the membranes
36. Fetal biophysical profile versus amniocentesis in predicting infection in preterm premature rupture of the membranes
37. The relationship between oligohydramnios and the onset of preterm labor in preterm premature rupture of membranes
38. Premature rupture of the membranes between 20 and 25 weeks' gestation: Role of amniotic fluid volume in perinatal outcome
39. Fetal behavior in preterm premature rupture of the membranes
40. Fetal body and breathing movements as predictors of intra-amniotic infection in preterm premature rupture of the membranes
41. Managing PROM: A continuing controversy
42. Outpatient versus inpatient management of PPROM
43. Is home management of preterm premature rupture of the membranes safe?
44. Preterm premature rupture of membranes: A randomized study of home versus hospital management
45. Outcome and cost analysis of preterm premature rupture of membranes in an outpatient setting
46. Prelabor rupture of the membranes at term: Expectant management at home or in hospital?
47. Intrapartumm fetal monitoring in preterm deliveries: Prospective study
48. Prophylactic intrapartum amnioinfusion in patients with preterm premature rupture of membranes
49. Preterm birth
50. Dynamics and disorders of amniotic fluid
51. Antepartum surveillance in preterm rupture of membranes
52. Recurrent chorioamnionitis and maternal septicemia: A case of successful in utero therapy
53. Use of parenteral antibiotic therapy to eradicate bacterial colonization of amniotic fluid in premature rupture of membranes
54. Chorioamnionitis in the preterm gestation
55. Maternal assessment in the prediction of intrauterine infection in preterm prelabour amniorrhexis
56. Conservative management of preterm premature rupture of the fetal membranes in a low socioeconomic population
57. Studies on saliva in menstruating, pregnant, and post-menopausal women
58. Can amniotic fluid analysis predict infection?
59. Management of amniocentesis in women with oligohydramnios due to membrane rupture: Evaluation of a cervical adapter
60. The use of a modified vaginal pouch for the diagnosis and management of premature rupture of the membrnes
61. The use of amniocentesis in patients with premature rupture of membranes
62. Amniotic fluid analysis: Its role in maternal and neonatal infection
63. Premature rupture of membranes
64. Amniocentesis for Gram stain and culture in preterm premature rupture of the membranes
65. Amniotic fluid glucose and intraamniotic infection
66. Evaluation of rapid diagnostic tests in the detection of microbial invasion of the amniotic cavity
67. A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and Gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes
68. Maternal blood C-reactive protein, white blood cell count, and temperature in preterm labor: A comparison with amniotic fluid white blood cell count
69. Antibiotic therapy for preterm premature rupture of the membranes
70. Antimicrobial therapy in expectant management of preterm premature rupture of the membranes
71. Antibiotic treatment in preterm premature rupture of membranes and neonatal morbidity: A meta-analysis
72. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes: A randomized controlled trial
73. Antibiotic prophylaxis in preterm premature rupture of the membranes: A prospective randomized double-blind trial of 220 patients
74. Antimicrobial therapy in preterm premature rupture of membranes: Results of a prospective, double-blind, placebo-controlled trial of erythromycin
75. Antibiotic therapy for preterm premature rupture of membranes
76. A prospective randomized double blind trial of ampicillin with and without sulbactam in preterm premature rupture of the membranes
77. Expanded-spectrum antibiotics with preterm premature rupture of membranes
78. Adverse perinatal outcome in resistant Enterobacteriaciae after antibiotic usage for premature rupture of the membranes and group B streptococcus carriage
79. Morbidity and mortality of infants weighing less than 1000 grams in an intensive care nursery
80. Fetal lung maturity: Mode of onset of premature labor. Influence of premature rupture of the membranes
81. Premature labor and premature rupture of the membranes
82. Antenatal glucocorticoid therapy for the prevention of respiratory disress syndrome in the premature infant
83. Acceleration of pulmonary surfactant maturation in stressed pregnancies: A study of neonatal lung effluent
84. Management of the patient with premature rupture of membranes
85. Management of preterm premature rupture of membranes: Assessing amniotic fluid in the vagina for phosphatidylglycerol
86. Comparison of phospholipids in vaginal and amniocentesis specimens of patients with premature rupture of membranes
87. Comparison of amniotic fluid lung maturity profiles in paired vaginal and amniocentesis specimens
88. Bacteria causing false positive test for phosphatidylglycerol in amniotic fluid
89. A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation
90. Management of preterm prematurely rupture membranes: A prospective randomized comparison of observation versus use of steroids and timed delivery
91. Effectiveness of antenatal steroids in obstetric subgroups
92. The effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome in preterm gestations with premature rupture of membranes
93. Effectiveness of antenatal corticosteroid administration after preterm premature rupture of the membranes
94. Preterm premature ruptured membranes: A randomized trial of steroids after treatment with antibiotics
95. Antenatal corticosteroid therapy: A metaanalysis of the randomized trials, 1972-1994
96. Do antenatal corticosteriods help in the setting of preterm rupture of membranes?
97. Antenatal steroids and intraventricular hemorrhage after premature rupture of membranes at 24 to 28 weeks' gestation
98. National Institutes of Health NIH Consensus Development Conference statement: Effect of corticosteroids for fetal maturation on perinatal outcomes, February 28-March 2, 1994
99. ACOG Committee Opinion
100. Physical development and medical history of children who were treated antenatalloy with corticosteroids to prevent respiratory distress syndrome: A 10 to 12-year follow-up
101. Association between rupture membranes, tocolytic therapy, and respiratory distress syndrome
102. Selected issues in premature rupture of the membranes: Herpes, cerclage, twins, tocolysis, and hospitalization
103. Oral ritodrine and preterm premature rupture of membranes
104. Impact of residual amniotic fluid volume in patients receiving parenteral tocolysis after premature rupture of the membranes
105. Conservative management of second trimester post-amniocentesis fluid leakage
106. Analysis of 2136 genetic amniocentesis: Experience of a single physician
107. Etiology of preterm rupture of membranes
108. Midtrimester premature rupture of the membranes
109. Pregnancy outcome after premature rupture of the membranes at or before 26 weeks' gestation
110. The effect of very prolonged membrane rupture on fetal development
111. Pregnancy outcome following preterm premature rupture of the membranes at less than 26 weeks gestation
112. Premature rupture of membranes before fetal viability
113. Risk factors for pulmonary hypoplasia in second trimester premature rupture of membranes
114. Neonatal outcome after prolonged preterm rupture of the membranes
115. Management of premature rupture of membranes before 26 weeks' gestation
116. Cases with ruptured membranes that "reseal."
117. The amnioinfusion therapy of saline solution for premature rupture of the membranes before 27 weeks gestational age
118. Role of amnioinfusion in the management of premature rupture of the membranes at <26 weeks' gestation
119. Amnioinfusion: A review
120. Treatment of premature rupture of the fetal membranes by means of fibrin adnesion
121. Intracervical fibrin sealants: A potential treatment for early preterm premature rupture of the membranes
122. Treatment of iatrogenic previable premature rupture of membranes with intra-amniotic injection of platelets and cryoprecipitate (amniopatch): Preliminary experience
123. In vitro studies of the interactions between platelets and amniotic membranes: A potential treatment for preterm premature rupture of the membranes
124. Prognostic factors and complication rates for cervical cerclage: A review of 482 cases
125. Surgical treatment of patients with hour glass shaped or ruptured membranes prior to the twentyfifth week of gestation
126. Management of cervical cerclage and preterm premature rupture of the membranes: Should the stitch be removed?
127. Timing of cerclage removal after preterm premature rupture of membranes: Maternal and neonatal outcomes
128. Poor perinatal outcome associated with retained cerclage in patients with premature rupture of membranes
129. Outcome of expectant management in preterm premature rupture of membranes with cervical cerclage in place
130. Treatments of preterm premature rupture of the membranes: A meta-analysis